Exact Sciences Corp. is a molecular diagnostics company focused on the early detection of the deadliest forms of cancer. The company has exclusive intellectual property protecting its non-invasive, molecular screening technology for the detection of colorectal cancer. We are driven to find ambitious, dynamic individuals who thrive in a team-based environment and can help us take another step toward winning the war on cancer through early detection. Mission: Cancer is detected too late. At Exact Sciences, we’re committed to using our proven expertise and determination to change lives by detecting cancer earlier. We deliver life-changing innovations to give people the confidence to make more effective decisions. That’s our promise.
1001 to 5000
TypeCompany - Public (EXAS)
Revenue$100 to $500 million (USD)
IndustryHealth Care Services & Hospitals
CompetitorsUnknown
Founded1995